West Pharmaceutical Services, Inc. (WST) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $385.73 --0%
Revenue Growth %: -3.0%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Revenue Growth %: -3.0%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.79, $0.10 better than the analyst estimate of $0.69. Revenue for the quarter came in at $324.8 million versus the consensus estimate of $321.5 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- West Pharma (WST) Tops Q1 EPS by 26c, provides guidance
- Kearny Financial (KRNY) Tops Q3 EPS by 1c
- ACNB Corporation (ACNB) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
